13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-13, with 69 holding rows worth $279,334,000.
- Accession
- 0001387131-21-008523
- Filer
- CIK 1773195
- Filed
- 2021-08-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 69 entries on the cover page, a total value of $279,334,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $279,334,000 with VALUE read as thousands by filing date, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 550,000 | $33,528,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 200,000 | $27,080,000 | thousands by filing date | put |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 225,000 | $20,813,000 | thousands by filing date | put |
| MORPHIC HLDG INC | 61775R105 | COM | 246,201 | $14,129,000 | thousands by filing date | |
| CUREVAC N V | N2451R105 | COM | 150,000 | $11,022,000 | thousands by filing date | put |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 838,311 | $10,890,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 900,000 | $9,090,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 425,000 | $8,861,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 85,000 | $7,929,000 | thousands by filing date | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 142,418 | $7,577,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 700,000 | $7,504,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 55,000 | $6,902,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 140,100 | $6,288,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 7,000,000 | $5,993,000 | thousands by filing date | principal |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 120,000 | $5,315,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 650,000 | $5,246,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 200,000 | $5,124,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 275,000 | $4,829,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 25,000 | $4,238,000 | thousands by filing date | call |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 250,000 | $3,545,000 | thousands by filing date | |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 300,000 | $3,060,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 75,000 | $2,992,000 | thousands by filing date | call |
| MODERNA INC | 60770K107 | COM | 12,500 | $2,937,000 | thousands by filing date | call |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 300,000 | $2,895,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 200,000 | $2,824,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 60,000 | $2,647,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 20,000 | $2,631,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 100,000 | $2,602,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 25,000 | $2,341,000 | thousands by filing date | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 200,000 | $2,266,000 | thousands by filing date | |
| CYCLACEL PHARMACE 6percent PFDCONV | 23254L603 | Stock | 380,000 | $2,250,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 80,000 | $2,149,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 650,000 | $2,061,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 25,000 | $2,060,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 70,000 | $2,000,000 | thousands by filing date | |
| SCHRODINGER INC COM | 80810D103 | Stock | 25,000 | $1,890,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 20,000 | $1,747,000 | thousands by filing date | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 25,000 | $1,687,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 50,000 | $1,672,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 10,000 | $1,619,000 | thousands by filing date | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 2,000,000 | $1,605,000 | thousands by filing date | principal |
| LIFESCI ACQUISITION II CORP | 53229E103 | COM | 150,000 | $1,500,000 | thousands by filing date | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 66,957 | $1,487,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155102 | COM CL A | 100,000 | $1,448,000 | thousands by filing date | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 20,000 | $1,387,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 70,000 | $1,385,000 | thousands by filing date | |
| ACUTUS MED INC | 005111109 | COM | 80,000 | $1,358,000 | thousands by filing date | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 50,000 | $1,198,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 45,000 | $1,159,000 | thousands by filing date | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 85,000 | $1,154,000 | thousands by filing date | |
| BCTG ACQUISITION CORP | 05492W103 | COM | 100,000 | $1,138,000 | thousands by filing date | |
| VAXCYTE INC COM | 92243G108 | Stock | 50,000 | $1,126,000 | thousands by filing date | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 72,466 | $1,043,000 | thousands by filing date | |
| ZYMEWORKS INC | 98985W102 | COM | 30,000 | $1,041,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 15,000 | $972,000 | thousands by filing date | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 300,000 | $933,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K105 | COM CL A | 75,000 | $920,000 | thousands by filing date | |
| CHARDAN HEALTHCR ACQSTN 2 CO | 15957T206 | UNIT 99/99/9999 | 75,000 | $819,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 80,000 | $783,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 20,000 | $700,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 50,000 | $694,000 | thousands by filing date | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 190,000 | $654,000 | thousands by filing date | |
| ITEOS THERAPEUTICS INC | 46565G104 | COM | 25,000 | $641,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 10,000 | $632,000 | thousands by filing date | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 75,000 | $475,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 30,000 | $317,000 | thousands by filing date | call |
| THE BEAUTY HEALTH COMPANY | 88331L116 | *W EXP 05/04/202 | 45,000 | $288,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 7,500 | $210,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,333 | $34,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-21-008523 | this filing | 2021-08-13 | acceptance time not in the bulk data set |